Editorial - Asian Journal of Biomedical and Pharmaceutical Sciences (2021) Volume 11, Issue 76

COVID-19 vaccines and the possibilities and the challenges into the future

The development of a replacement vaccine usually consists of a linear sequence of several steps and lasts a few years. The sudden outbreak of the SARS-CoV-2/COVID-19 pandemic urged for a fast response and led to an unprecedented effort to supply a vaccine against this virus during a very short time, within the context of very limited pre-existing clinical experience with any coronavirus vaccine and with multiple steps of development administered in parallel, with the deployment of various technologies, a number of which haven't been utilized in a licensed vaccine before. There's a robust need for vaccines against SARS-CoV-2 as they potentially represent a robust tool to counteract the spread of the virus together with nonpharmaceutical interventions that, although essential, aren't ready to control it sustainably, and within the absence of an efficient therapeutic protocol against COVID-19

Author(s): Fook Yee Chye

Abstract PDF